Among HBV/HCV coinfected people, about half have dominant hepatitis B
virus while half have dominant hepatitis C, and those with active HBV
replication are at higher risk of liver-related complications and death,
according to study findings presented at Digestive Disease Week this
month in Chicago.
Due to similar routes of transmission, many people are coinfected with
both hepatitis B virus (HBV) and hepatitis C virus (HCV). Previous
research has shown that the 2 viruses can interact with one another,
with HBV suppressing HCV replication and vice versa. Patterns of viral
dominance are unpredictable, however, and their effects on clinical
outcomes are unclear.
Robert Kruse from the Center for Innovations in Quality, Effectiveness
and Safety and colleagues conducted a retrospective cohort study of
hepatitis C patients who received care at through the U.S. Veterans
Administration health system between 1997 and 2005.